Skip to Main Content

Paper Details

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma.
Front Oncol
3
2022
Author NameAffiliation
John M KirkwoodUniversity of Pittsburgh Medical Center Hillman Cancer Centet
  • 1 - 1

Datasets

Release 1.2